Drug General Information (ID: DDI7KVRSYT)
Drug Name			Ramipril		Drug Info		Dalteparin		Drug Info
Drug Type		Small molecule				Small molecule
Therapeutic Class		Antihypertensive Agents				Anticoagulants
Structure

Mechanism of Ramipril-Dalteparin Interaction (Severity Level: Moderate)
Increased risk of hyperkalemia Click to Show/Hide Mechanism Graph
Drug Name		Ramipril				Dalteparin
Mechanism		Hyperkalemia				Hyperkalemia
Key Mechanism Factor 1
		Factor Name		Hyperkalemia
		Factor Description		Hyperkalemia is a condition in which the level of potassium in the blood is higher than normal. While mild cases may not produce symptoms, severe hyperkalemia can lead to fatal arrhythmias if left untreated.
Mechanism Description		Increased risk of hyperkalemia by the combination of Ramipril and Dalteparin

Recommended Action
Management		Caution is advised if ACE inhibitors or ARBs are used with heparin or low molecular weight heparin. Serum potassium and renal function should be checked regularly.

References
1	Product Information. Diovan (valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
2	Product Information. Micardis (telmisartan). Boehringer-Ingelheim, Ridgefield, CT.
3	Product Information. Avapro (irbesartan). Bristol-Myers Squibb, Princeton, NJ.
4	Product Information. Atacand (candesartan). Astra Pharmaceuticals, Wayne, PA.
5	Product Information. Teveten (eprosartan). SmithKline Beecham, Philadelphia, PA.
6	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
7	Product Information. Cozaar (losartan). Merck & Co, Inc, West Point, PA.
8	Perazella MA "Drug-induced hyperkalemia: old culprits and new offenders." Am J Med 109 (2000): 307-14. [PMID: 10996582]
9	Product Information. Edarbi (azilsartan). Takeda Pharmaceuticals America, Lincolnshire, IL.
10	Product Information. Benicar (olmesartan). Sankyo Parke Davis, Parsippany, NJ.